Kinase regulation by hydrophobic spine assembly in cancer

Molecular and Cellular Biology

Volumn 35, Issue 1, 2015, Pages 264-276

  Hu, Jiancheng ^a,b   Ahuja, Lalima G ^c   Meharena, Hiruy S ^c   Kannan, Natarajan ^d   Kornev, Alexandr P ^b,c   Taylor, Susan S ^b,c   Shaw, Andrey S ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ABL1 PROTEIN; ADENOSINE TRIPHOSPHATE; B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; PHENYLALANINE; UNCLASSIFIED DRUG; BRAF PROTEIN, HUMAN; HISTIDINE; METHIONINE; PHOSPHOTRANSFERASE;

ALLOSTERISM; ALPHA HELIX; ARTICLE; CATALYSIS; CONFORMATION; GENE MUTATION; HYDROPHOBICITY; NEOPLASM; PHENOTYPE; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN STRUCTURE; REGULATORY MECHANISM; SURFACE PROPERTY; BINDING SITE; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN SECONDARY STRUCTURE;

ADENOSINE TRIPHOSPHATE; ALLOSTERIC SITE; CATALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HISTIDINE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; METHIONINE; MODELS, MOLECULAR; MUTATION; NEOPLASMS; PHOSPHOTRANSFERASES; PROTEIN STRUCTURE, SECONDARY; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-ABL; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84919968938     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00943-14     Document Type: Article

References (29)

1. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. 2002. The protein kinase complement of the human genome. Science 298:1912-1934. http://dx.doi.org/10.1126/science.1075762.
2. Taylor SS, Kornev AP. 2011. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci 36:65-77. http://dx.doi.org/10.1016/j.tibs.2010.09.006.
3. Kornev AP, Taylor SS, Ten Eyck LF. 2008. A helix scaffold for the assembly of active protein kinases. Proc Natl Acad Sci U S A 105:14377-14382. http://dx.doi.org/10.1073/pnas.0807988105.
4. Hu J, Stites EC, Yu H, Germino EA, Meharena HS, Stork PJS, Kornev AP, Taylor SS, Shaw AS. 2013. Allosteric activation of functionally asymmetric RAF kinase dimers. Cell 154:1036-1046. http://dx.doi.org/10.1016/j.cell.2013.07.046.
5. Baccarini M. 2005. Second nature: biological functions of the Raf-1 "kinase." FEBS Lett 579:3271-3277. http://dx.doi.org/10.1016/j.febslet.2005.03.024.
6. Matallanas D, Birtwistle M, Romano D, Zebisch A, Rauch J, von Kriegsheim A, Kolch W. 2011. Raf family kinases: old dogs have learned new tricks. Genes Cancer 2:232-260. http://dx.doi.org/10.1177/1947601911407323.
7. Morrison DK, Cutler RE. 1997. The complexity of Raf-1 regulation. Curr Opin Cell Biol 9:174-179. http://dx.doi.org/10.1016/S0955-0674(97)80060-9.
8. Ory S, Morrison DK. 2004. Signal transduction: IMPlications for Rasdependent ERK signaling. Curr Biol 14:R277-R278. http://dx.doi.org/10.1016/j.cub.2004.03.023.
9. Wimmer R, Baccarini M. 2010. Partner exchange: Protein-protein interactions in the Raf pathway. Trends Biochem Sci 35:660-668. http://dx.doi.org/10.1016/j.tibs.2010.06.001.
10. Hu J, Yu H, Kornev AP, Zhao J, Filbert EL, Taylor SS, Shaw AS. 2011. Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF. Proc Natl Acad Sci U S A 108:6067-6072. http://dx.doi.org/10.1073/pnas.1102554108.
11. Gosal G, Kochut KJ, Kannan N. 2011. Prokino: an ontology for integrative analysis of protein kinases in cancer. PLoS One 6:e28782. http://dx.doi.org/10.1371/journal.pone.0028782.
12. ManChon U, Talevich E, Katiyar S, Rasheed K, Kannan N. 2014. Prediction and prioritization of rare oncogenic mutations in the cancer kinome using novel features and multiple classifiers. PLoS Comput Biol 10:e1003545. http://dx.doi.org/10.1371/journal.pcbi.1003545.
13. Qin J, Xie P, Ventocilla C, Zhou G, Vultur A, Chen Q, Liu Q, Herlyn M, Winkler J, Marmorstein R. 2012. Identification of a novel family of BRAF(V600E) inhibitors. J Med Chem 55:5220-5230. http://dx.doi.org/10.1021/jm3004416.
14. Fiser A, Sali A. 2003. ModLoop: automated modeling of loops in protein structures. Bioinformatics 19:2500-2501. http://dx.doi.org/10.1093/bioinformatics/btg362.
15. Kornev AP, Taylor SS. 2009. Pseudokinases: functional insights gleaned from structure. Structure 17:5-7. http://dx.doi.org/10.1016/j.str.2008.12.005.
16. Zhang BH, Guan KL. 2000. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J 19:5429-5439. http://dx.doi.org/10.1093/emboj/19.20.5429.
17. Rajakulendran T, Sahmi M, Lefrançois M, Sicheri F, Therrien M. 2009. A dimerization-dependent mechanism drives RAF catalytic activation. Nature 461:542-545. http://dx.doi.org/10.1038/nature08314.
18. Meharena HS, Chang P, Keshwani MM, Oruganty K, Nene AK, Kannan N, Taylor SS, Kornev AP. 2013. Deciphering the structural basis of eukaryotic protein kinase regulation. PLoS Biol 11:e1001680. http://dx.doi.org/10.1371/journal.pbio.1001680.
19. Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, McCormick F, Rauen KA. 2006. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311:1287-1290. http://dx.doi.org/10.1126/science.1124642.
20. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JWC, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. 2002. Mutations of the BRAF gene in human cancer. Nature 417:949-954. http://dx.doi.org/10.1038/nature00766.
21. Wan PTC, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Project CG, Jones CM, Marshall CJ, Springer CJ, Barford D, Marais R. 2004. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116:855-867. http://dx.doi.org/10.1016/S0092-8674(04)00215-6.
22. ScheeffED, Eswaran J, Bunkoczi G, Knapp S, Manning G. 2009. Structure of the pseudokinaseVRK3reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. Structure 17:128-138. http://dx.doi.org/10.1016/j.str.2008.10.018.
23. Shaw AS, Kornev AP, Hu J, Ahuja LG, Taylor SS. 2014. Kinases and pseudokinases: lessons learned from RAF. Mol Cell Biol 34:1538-1546. http://dx.doi.org/10.1128/MCB.00057-14.
24. Lanzarotti E, Biekofsky RR, Estrin DA, Marti MA, Turjanski AG. 2011. Aromatic-aromatic interactions in proteins: beyond the dimer. J Chem Infect Model 51:1623-1633. http://dx.doi.org/10.1021/ci200062e.
25. Johnson DA, Akamine P, Radzio-Andzelm E, Madhusudan M, Taylor SS. 2001. Dynamics of cAMP-dependent protein kinase. Chem Rev 101:2243-2270. http://dx.doi.org/10.1021/cr000226k.
26. Iyer GH, Garrod S, Woods VL, Taylor SS. 2005. Catalytic independent functions of a protein kinase as revealed by a kinase-dead mutant: study of the Lys72His mutant of cAMP-dependent kinase. J Mol Biol 351:1110-1122. http://dx.doi.org/10.1016/j.jmb.2005.06.011.
27. Steichen JM, Iyer GH, Li S, Saldanha SA, Deal MS, Woods VL, Taylor SS. 2010. Global consequences of activation loop phosphorylation on protein kinase A. J Biol Chem 285:3825-3832. http://dx.doi.org/10.1074/jbc. M109.061820.
28. Steichen JM, Kuchinskas M, Keshwani MM, Yang J, Adams JA, Taylor SS. 2012. Structural basis for the regulation of protein kinase A by activation loop phosphorylation. J Biol Chem 287:14672-14680. http://dx.doi.org/10.1074/jbc. M111.335091.
29. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. 2006. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125:1137-1149. http://dx.doi.org/10.1016/j.cell.2006.05.013.